Development of an algorithm for determination of the likelihood of virological failure in HIV-positive adults receiving antiretroviral therapy in decentralized care

References

• Department of Health and Human Services. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2016 [ cited 2017 Aug 22]. Available from: http://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf
   Google Scholar
• European AIDS Clinical Society. HIV guidelines 8.1. 2016 [ cited 2017 Aug 22]. Available from: http://www.eacsociety.org/files/guidelines_8.1-english.pdf
   Google Scholar
• Haas AD, Keiser O, Balestre E, et al. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis. Lancet HIV. 2015;2:e271–8.
   PubMed Web of Science ®Google Scholar
• Phillips AN, Pillay D, Garnett G, et al. Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings. Aids. 2011;25:843–850.
   PubMed Web of Science ®Google Scholar
• Boender TS, Kityo CM, Boerma RS, et al. Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa. J Antimicrob Chemother. 2016;71:2918–2927.
   PubMed Web of Science ®Google Scholar
• Bonner K, Mezochow A, Roberts T, et al. Viral load monitoring as a tool to reinforce adherence: a systematic review. J Acquir Immune Defic Syndr. 2013;64:74–78.
   PubMed Web of Science ®Google Scholar
• Ouattara EN, Robine M, Eholié SP, et al. Laboratory monitoring of antiretroviral therapy for HIV infection: cost-effectiveness and budget impact of current and novel strategies. Clin Infect Dis. 2016;62:1454–1462.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: World Health Organization; 2016.
   Google Scholar
• Joint United Nations Programme on HIV/AIDS. Global AIDS update 2016. Geneva; 2016 [ cited 2017 Aug 22]. Available from: http://www.unaids.org/sites/default/files/media_asset/global-AIDS-update-2016_en.pdf
   Google Scholar
• Lecher S, Williams J, Fonjungo PN, et al. Progress with scale-up of HIV viral load monitoring — seven Sub-Saharan African Countries, January 2015–June 2016. MMWR Morb Mortal Wkly Rep. 2016;65:1332–1335.
   PubMed Web of Science ®Google Scholar
• Roberts T, Cohn J, Bonner K, et al. Scale-up of routine viral load testing in resource-poor settings: current and future implementation challenges. Clin Infect Dis. 2016;62:1043–1048.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource constrained settings. Geneva: World Health Organization; 2011.
   Google Scholar
• Balcha TT, Skogmar S, Sturegard E, et al. A clinical scoring algorithm for determination of the risk of tuberculosis in HIV-infected adults: a cohort study performed at Ethiopian Health Centers. Open Forum Infect Dis. 2014;1:ofu095–ofu095.
   PubMedGoogle Scholar
• Lynen L, An S, Koole O, et al. An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia. J Acquir Immune Defic Syndr. 2009;52:40–48.
   PubMed Web of Science ®Google Scholar
• Aboxuyannis M, Menten J, Kiragga A, et al. Development and validation of systems for rational use of viral load testing in adults receiving first-line ART in sub-Saharan Africa. Aids. 2011;25:1627–1635.
   PubMed Web of Science ®Google Scholar
• Evans DH, Maskew M, Fox M, et al. CD4 criteria improves the sensitivity of a clinical algorithm developed to identify viral failure in HIV-positive patients on first-line antiretroviral therapy. J Int Aids Soc. 2014;17:1–9.
   Web of Science ®Google Scholar
• Meya D, Spacek LA, Tibenderana H, et al. Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria. J Int AIDS Soc. 2009;12:3.
   PubMed Web of Science ®Google Scholar
• Rutherford GW, Anglemyer A, Easterbrook PJ, et al. Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure. Aids. 2014;28:S161–S169.
   PubMed Web of Science ®Google Scholar
• Ethiopian Federal Ministry of Health. Health Sector Transformation Plan - Annual Performance Report EFY 2008 (2015/2016). Addis Ababa; 2016 [ cited 2017 Aug 22]. Available from: http://www.moh.gov.et/web/guest/-/health-sector-transformation-plan-i-annual-performance-report-arm_2016-?inheritRedirect=true
   Google Scholar
• National AIDS Resource Center. HIV/AIDS Estimates and Projections in Ethiopia, 2011-2016. 2016 [ cited 2017 Aug 22]. Available from: http://fitun.etharc.org/resources/finish/53-hiv-aids-estimates-and-projections/327-hiv-aids-estimates-and-projections-in-ethiopia-2011-2016
   Google Scholar
• Ministry of Health of Ethiopia. National Guidelines for Comprehensive HIV Prevention, Care and Treatment. 2014 [ cited 2017 Aug 22]. Available from: https://aidsfree.usaid.gov/sites/default/files/ethiopia_natl_gl_2014.pdf
   Google Scholar
• Balcha TT, Sturegård E, Winqvist N, et al. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture. PLoS One. 2014;9:e85478.
   PubMed Web of Science ®Google Scholar
• Reepalu A, Balcha TT, Skogmar S, et al. High rates of virological suppression in a cohort of human immunodeficiency virus-positive adults receiving antiretroviral therapy in Ethiopian health centers irrespective of concomitant tuberculosis. Open Forum Infect Dis. 2014;1:ofu039–ofu039.
   PubMedGoogle Scholar
• Mannheimer SB, Mukherjee R, Hirschhorn LR, et al. The CASE adherence index: A novel method for measuring adherence to antiretroviral therapy. AIDS Care. 2006;18:853–861.
   PubMed Web of Science ®Google Scholar
• World Health Organization. March 2014 Supplement to the 2013 consolidated guidelines on use of antiretroviaral drugs for treating and preventing HIV infection - recommendations for a public health approach. Geneva: World Health Organization; 2014.
   Google Scholar
• World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva: World Health Organization; 2011.
   Google Scholar
• Tang AM, Dong K, Deitchler M, et al. Use of Cutoffs for Mid-Upper Arm Circumference (MUAC) as an indicator or predictor of nutritional and health- related outcomes in adolescents and adults: a systematic review. Washington (DC): FHI 360/FANTA; 2013.
   Google Scholar
• Médecins Sans Frontières (MSF). Putting HIV and HCV to the Test: A Product Guide for Point-of-Care CD4 and Laboratory-Based and Point-of-Care Virological HIV and HCV Tests. MSF; 2015 [cited 2017 Aug 22]. Available from: https://www.msfaccess.org/sites/default/files/HIV_HCV_Report_Diagnostic_Guide_2015.pdf
   Google Scholar
• Van Griensven J, Phan V, Thai S, et al. Simplified clinical prediction scores to target viral load testing in adults with suspected first line treatment failure in Phnom Penh, Cambodia. PLoS One. 2014;9:1–5.
   Web of Science ®Google Scholar
• Reepalu A, Balcha TT, Skogmar S, et al. Factors associated with early mortality in HIV-positive men and women investigated for tuberculosis at Ethiopian health centers. PLoS One. 2016;11:1–13.
   Google Scholar
• Liu E, Spiegelman D, Semu H, et al. Nutritional status and mortality among HIV-infected patients receiving antiretroviral therapy in Tanzania. J Infect Dis. 2011;204:282–290.
   PubMed Web of Science ®Google Scholar
• Boulle A, Van Cutsem G, Hilderbrand K, et al. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. Aids. 2010;24:563–572.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Progress report. Global health sector response to HIV, 2000–2015. Focus on innovations in Africa. Geneva: World Health Organization; 2015.
   Google Scholar
• Ying R, Granich RM, Gupta S, et al. CD4 cell count: declining value for antiretroviral therapy eligibility. Clin Infect Dis. 2016;62:1022–1028.
   PubMed Web of Science ®Google Scholar
• Koller M, Fatti G, Chi BH, et al. Implementation and operational research: risk charts to guide targeted HIV-1 viral load monitoring of ART: development and validation in patients from resource-limited settings. J Acquir Immune Defic Syndr. 2015;70:e110–9.
   PubMed Web of Science ®Google Scholar
• Yotebieng M, Maskew M, Van Rie A. CD4+ gain percentile curves for monitoring response to antiretroviral therapy in HIV-infected adults. Aids. 2015;29:1067–1075.
   PubMed Web of Science ®Google Scholar
• Siedner MJ, Ng CK, Bassett IV, et al. Trends in CD4 count at presentation to care and treatment initiation in Sub-Saharan Africa, 2002-2013: a meta-analysis. Clin Infect Dis. 2015;60:1120–1127.
   PubMed Web of Science ®Google Scholar
• Phan V, Thai S, Koole O, et al. Validation of a clinical prediction score to target viral load testing in adults with suspected first-line treatment failure in resource-constrained settings. J Acquir Immune Defic Syndr. 2013;62:509–516.
   PubMed Web of Science ®Google Scholar
• Alemnji G, Onyebujoh P, Nkengasong JN. Improving laboratory efficiencies to scale-up HIV viral load testing. Curr Opin HIV AIDS. 2017;12(2):165–170.
   PubMed Web of Science ®Google Scholar
• Peter T, Ellenberger D, Kim AA, et al. Early antiretroviral therapy initiation: access and equity of viral load testing for HIV treatment monitoring. Lancet Infect Dis. 2016;3099:2014–2017.
   Google Scholar